Printed From BioPortfolio.com
Allele Receives iPSC Patents Bolstering Current Production of Multiple Lines at Wholly Owned cGMP Facility
03:00 EDT 31 Oct 2018 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Allele Biotechnology & Pharmaceuticals Inc. has received issuance
notices from the U.S. Patent and Trademark Office for its first batch of
patents covering the derivation of induced pluripotent stem cells
(iPSCs). Allele’s...
Other Sources for this Article
Allele
Carole Zeleny
czeleny@allelebiotech.com
